Safety, Tolerability, And Pharmacokinetics Of Tak-701, A Humanized Anti-Hepatocyte Growth Factor (Hgf) Monoclonal Antibody, In Patients With Advanced Nonhematologic Malignancies: First-In-Human Phase I Dose-Escalation Study.
JOURNAL OF CLINICAL ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要